| Pharmaceutical Information |
| Drug Name |
Levobetaxolol hydrochloride |
| Drug ID |
BADD_D01266 |
| Description |
A cardioselective beta-1-adrenergic antagonist with no partial agonist activity. |
| Indications and Usage |
For the management of hypertension. |
| Marketing Status |
approved; investigational |
| ATC Code |
S01ED02; C07AB05 |
| DrugBank ID |
DB00195
|
| KEGG ID |
D04710
|
| MeSH ID |
D015784
|
| PubChem ID |
60656
|
| TTD Drug ID |
D03ROX
|
| NDC Product Code |
42806-039; 24658-700; 42806-038; 24658-701 |
| UNII |
8MR4W4O06J
|
| Synonyms |
Betaxolol | Betaxolol Hydrochloride | Hydrochloride, Betaxolol | Kerlone | Oxodal | Kerlon | SL-75212 | SL 75212 | SL75212 | ALO-1401-02 | ALO 1401 02 | ALO140102 | Betoptic | Betoptima | Betaxolol Alcon | Alcon, Betaxolol |
|
| Chemical Information |
| Molecular Formula |
C18H30ClNO3 |
| CAS Registry Number |
116209-55-3 |
| SMILES |
CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
